SciELO - Scientific Electronic Library Online

 
vol.77 número1Factores de riesgo de obesidad en escolares de primer año básico de Punta ArenasTamizaje clínico y análisis de mutaciones en el gen FMR1 en 99 varones con características clínicas del síndrome de X-frágil índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Revista chilena de pediatría

versión impresa ISSN 0370-4106

Resumen

SOTOMAYOR F, Cristián et al. Clinical characteristics of Inmune Thrombocytopenic Purpura. Rev. chil. pediatr. [online]. 2006, vol.77, n.1, pp. 27-33. ISSN 0370-4106.  http://dx.doi.org/10.4067/S0370-41062006000100004.

Background: Inmune thrombocytopenic purpura (ITP) is usually self-limited, but may have a chronic evolution when persisting more than 6 months (10-20% cases). Its treatment is controversial and few national data is available. Objective: To obtain knowledge on clinical and laboratory characteristics of ITP, its relationship with chronic evolution and treatment. Patients and Methods: Retrospective study that includes patients with diagnosis of ITP between March 1998 and February 2003 at Luis Calvo Mackenna Children's Hospital. We registered at diagnosis: sex, age, symptoms and treatment strategy. Platelet count (PC) was done at diagnosis, between day 15-60 and after 6 months. Fisher test and Odds ratio were calculated. Results: Median age was 4,4 years (0,7-16,1), initial PC was £ 20 000/mm3 in 37/52 cases. No cerebral bleeding was found. Observation strategy was used in 34/52 cases, steroids in 17/52 cases and steroids + inmunoglobulin in 1 case. The 6-months follow up was completed in 48/52 cases; 11 patients had a chronic evolution. We found an association with PC day 15 £ 20 000/mm3 (p = 0,01 OR = 9 IC95% 1,26-80,16) and PC day 60 £ 50 000/mm3 (p = 0,0000003 OR = 124 IC95% 7,77-4951,52). Conclusions: Most of our patients were successfully managed with the observation strategy. 23% cases had a chronic evolution and PC day 15 £ 20 000/mm3 and PC day 60 £ 50 000/mm3 are considered risk factors

Palabras llave : acute immune thrombocytopenic purpura; chronic immune thrombocytopenic purpura; outcome; treatment.

        · resumen en Español     · texto en Español